<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04586556</url>
  </required_header>
  <id_info>
    <org_study_id>20.198</org_study_id>
    <nct_id>NCT04586556</nct_id>
  </id_info>
  <brief_title>Artificial Intelligence for Real-time Detection and Monitoring of Colorectal Polyps</brief_title>
  <official_title>Artificial Intelligence for Real-time Detection and Monitoring of Colorectal Polyps</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre hospitalier de l'Université de Montréal (CHUM)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that the clinical implementation of an AI system is an optimal&#xD;
      tool to monitor, audit and improve the detection and classification of polyps during&#xD;
      colonoscopy. The objectives of this study are to generate preliminary data to evaluate the&#xD;
      effectiveness of AI-assisted colonoscopy on: a) the rate of detection of adenomas; b) the&#xD;
      histological classification of polyps (which would reduce the need for pathological&#xD;
      evaluation of polyps); c) the automatic evaluation of the quality of colonoscopy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this trial, the investigators aim to evaluate the followings:&#xD;
&#xD;
        1. the accuracy of automatic detection of important anatomical landmarks (i.e., ileocecal&#xD;
           valve, appendiceal orifice);&#xD;
&#xD;
        2. the accuracy of automatic detection of polyps/adenomas (PDR/ADR);&#xD;
&#xD;
        3. the accuracy of computer-assissted optical diagnosis of polyps size 1-10 mm compared to&#xD;
           the results of the histopathological examinations of the polyps as the reference&#xD;
           standard, and to the endocopists' prediction of polyps' histology;&#xD;
&#xD;
        4. the polyp miss rate (PMR) through verifying the short video sequences of the polyps&#xD;
           identified by the AI machine by the expert endoscopist(s);&#xD;
&#xD;
        5. the accuracy of automatic calculation of withdrawal time by the AI machine compared to&#xD;
           the reported withdrawal time by the endoscopists.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 18, 2020</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>prospective, multi-endoscopist, single center, clinical study at tertiary referral center (CHUM)</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of adenomas detected</measure>
    <time_frame>Day 1</time_frame>
    <description>Efficacy of AI assisted colonoscopy to detect the proportion of patients with at least 1 neoplastic polyp. Adenoma detection rate with an AI.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the automatic report of the colonoscopy quality indicators</measure>
    <time_frame>Day 1</time_frame>
    <description>Compare of the automatic detection of the ileocecal valve, appendiceal orifice, and the automatic calculation of the withdrawal time with manual detection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Polyp miss rate (PMR)</measure>
    <time_frame>Day 1</time_frame>
    <description>proportion of polyps that are detected by the AI machine but not by the endoscopists proportion of patients with either adenoma or carcinoma rate and type of adverse and serious adverse events occurring during the procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>prediction of polyp histology</measure>
    <time_frame>Day 14</time_frame>
    <description>evaluate the agreement of the optical diagnosis-based surveillance interval with the pathology-based recommendation assessing the prediction accuracy of advanced neoplasia proportion of patients for whom an immediate surveillance recommendation following the colonoscopy can be directly provided when using AI-assisted optical diagnosis and how often histopathology polyp examination would have been avoided by using this strategy.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Adenomatous Polyps</condition>
  <arm_group>
    <arm_group_label>Artificial intelligence for real-time detection and monitoring of colorectal polyps</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A standard colonoscopy will be performed according to the standard of routine care. All optically diagnosed polyps will be removed and sent to the CHUM pathology laboratory for histopathological evaluation according to institutional standards. The AI system will capture video of the procedure in real time, and provide additional information on the detection of polyps, follow-up and prediction of pathology. The full-length colonoscopy videos will be annotated for the exact time of the identification of the anatomical landmarks, polyps, also for polyp- and procedural-related characteristics.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Polyps detection by Artificial Intelligence</intervention_name>
    <description>The AI system will capture the live video of the procedure and the AI feedback (polyp detection, tracking, and pathology prediction) will be shown on a second screen installed next to the regular endoscopy screen. Screen A will show the regular endoscopy image and screen B will show the regular endoscopy image together with the areas that might harbor a polyp or the information to predict pathology</description>
    <arm_group_label>Artificial intelligence for real-time detection and monitoring of colorectal polyps</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria :&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
          -  Age 45-80 years&#xD;
&#xD;
          -  Indication to undergo a lower GI endoscopy.&#xD;
&#xD;
        Exclusion Criteria :&#xD;
&#xD;
          -  Coagulopathy&#xD;
&#xD;
          -  Poor general health, defined as an American Society of Anesthesiologists (ASA)&#xD;
             physical status class &gt;3&#xD;
&#xD;
          -  Emergency colonoscopies&#xD;
&#xD;
          -  Hospitalized patients&#xD;
&#xD;
          -  Known inflammatory bowel disease (IBD)&#xD;
&#xD;
          -  Patients currently in the emergency room&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Université de Montréal</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>QC H3T 1J4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Montréal</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maureen Fontaine</last_name>
      <phone>(514) 890-8000 Ext. 30655</phone>
      <email>maureen.fontaine.chum@ssss.gouv.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Daniel von Renteln, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simon Bouchard, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Erik Deslandres, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mickael Bouin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Audrey Weber, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sacha Sidani, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lisa di Jorio, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IHU Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 1, 2020</study_first_submitted>
  <study_first_submitted_qc>October 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2020</study_first_posted>
  <last_update_submitted>September 13, 2021</last_update_submitted>
  <last_update_submitted_qc>September 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Polyps detection</keyword>
  <keyword>Artificial Intelligence</keyword>
  <keyword>Adenoma detection</keyword>
  <keyword>Polyps classification</keyword>
  <keyword>Quality indicators</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenomatous Polyps</mesh_term>
    <mesh_term>Polyps</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

